@theNCI #OncTwitter #HemeTwitter #LymSm #MedTwitter Sources and further reading: Alizadeh et al., Nature 2000: https://t.co/6ia9a4CJeb Rosenwald et al., NEJM 2002: https://t.co/RTVWbYsg70 Davis et al., Nature 2010 (chronic active BCR in ABC): https…
@PR_pharma Since the discovery of cell-of-origin subtypes by @AshAlizadeh in 2000 (https://t.co/pTFyGA2CWd), ABC disease has empirically shown itself to be less responsive to RCHOP.
It’s been 20 years since Louis M. Staudt’s group first used molecular biomarkers to classify tumors. At BioIVT supports your need for well-annotated specimens with board-certified pathology confirmation and clearly identified cohorts. Read the publication…
@mbeisen really enjoying this paper of yours Lou Staudt referred to in a talk yesterday - the sheer complexity and heterogeneity involved are astonishing! https://t.co/5w5j0yt1qv